Netherlands· NL-3e6aacf23ce6

Antabus dispergetten 400 mg, bruistabletten

A disulfiram product containing disulfiram, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC N07BB01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about disulfiramAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Disulfiram is registered in 13 of 19 countries.

Countries holding a registration under ATC N07BB01 (disulfiram), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search disulfiram products by name

Disulfiram · ATC N07BB01

13 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of disulfiram costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.19 in Spain to $0.55 in Switzerland — a ×2.9 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Disulfiram · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

CH Switzerland$0.55
ES Spain$0.19

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: DISULFIRAM
Manufacturer: Aurobindo Pharma B.V.
Country: Netherlands (NL)
ATC code: N07BB01
ATC class: Disulfiram
Defined daily dose: 0.2 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
01032

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

210 interactions on record for disulfiram.

Graded by severity as the source publishes them — 19 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check disulfiram against other medicines How interaction checks work

Disulfiram · interactions on record

210 records

19 severe
163 moderate
15 minor
13 info

Most severe, free to view

EthanolB05XX04severe
MipomersenC10AX11severe
LomitapideC10AX12severe
MetronidazoleJ01XD01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Disulfiram in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All disulfiram products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

Czechia · Antabus
Germany · Tetraethylthiuramdisulfid Smartpractice Europe
Denmark · Antabus
Spain · Antabus
Finland · Antabus
France · Esperal
United Kingdom (Northern Ireland) · Antabuse, Disulfiram Accord-Uk
Hungary · Antaethyl
Ireland · Antabuse
Iceland · Antabus
Italy · Antabuse Dispergettes, Etiltox
Malta · Disural
Norway · Antabus
Poland · Anticol, Disulfiram Wzf
Portugal · Tetradin
Romania · Antalcol
Sweden · Antabus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/503c6a9a-6420-4835-b46f-6e1dbb6313ae
GET /v1/drugs/503c6a9a-6420-4835-b46f-6e1dbb6313ae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Bruistablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h01032_smpc.pdf",
  "strength": null,
  "atc_label": "Disulfiram",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg01032",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "NATRIUMWATERSTOFCARBONAAT (E 500 (II))",
    "POLYSORBAAT 20 (E 432)",
    "POVIDON (E 1201)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "WIJNSTEENZUUR, (L (+) Vorm) (E 334)"
  ],
  "substances": [
    "DISULFIRAM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h01032.pdf",
  "authorised_at": "1985/11/27",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "01032",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about disulfiram.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console